Skip to content

TO SEE THE EFFECT OF AYURVEDIC FORMULATION AND PROCEDURE IN THE MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME (PCOS)

A RANDOMIZED OPEN LABELLED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF TRIPHLADI TAILAM MATRA BASTI AND KUBERAKSH VATI IN THE MANAGEMENT OF POLYCYSTIC OVARIAN SYNDROME (PCOS) - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/01/079553
Enrollment
60
Registered
2025-01-27
Start date
Unknown
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N926- Irregular menstruation, unspecified

Interventions

None listed

Sponsors

Dr Pooja
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient willing to give voluntary informed consent 2 Female patient of age group between 16-40 years (both married and unmarried) ASRM / ESHRM (Rotterdam) criteria- Affected patient must follow two out of three criteria (1) Oligo and/or anovulation (2) Hyperandrogenism (clinical / biochemical) (3) Polycystic ovaries (confirmed or USG) 3 BMI more than 24.9

Exclusion criteria

Exclusion criteria: 1 Patient who is not willing to give voluntary informed consent 2 Women of age from 16years to 40 years 3 BMI less than 24.9 4 Patient with chronic systemic illness (cardiac failure cirrhosis of liver hypertension diabetes mellitus tuberculosis chronic renal disease) 5 Patient with reproductive system abnormalities (excluded clinically and radiologically hydrosalpinx endometrosis adenomyosis carcinoma of reproductive organ) 6 Long term medication 7 Any type of malignancy 8 Patient with positive STDs HIV Hepatitis B antigen (HBsAg) 9 Patient suffering from adrenal hyperplasia severe insulin resistant androgen secreting neoplasm thyroid abnormalities cushing syndrome

Design outcomes

Primary

MeasureTime frame
To reduce or resolve the number and size of cystTimepoint: FOLLOW UP FOR SUBJECTIVE SYMPTOMS AFTER EVERY 1 MONTH AND FOR OBJECTIVE SYMPTOMS AFTER 3 MONTHS

Secondary

MeasureTime frame
Changes in other associated clinical feature related to Polycystic ovarian syndrome (PCOS)Timepoint: FOLLOW UP FOR SUBJECTIVE SYMPTOMS AFTER EVERY 1 MONTH AND FOR OBJECTIVE SYMPTOMS AFTER 3 MONTHS

Countries

India

Contacts

Public ContactDr Pooja

Institue for Ayurved Studies and Research Umri Road Sector 08

drsunititanwar@gmail.com9996311778

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026